- Home
- XXII
as of 02-11-2026 11:28am EST
22nd Century Group Inc is a United States-based biotechnology company focused on utilizing alkaloid plant technologies to improve health and wellness with reduced nicotine tobacco, and hemp/cannabis. It has one operating segment; The tobacco segment is engaged in commercializing its proprietary VLNC tobacco plants and cigarette products, which contain nicotine than conventional tobacco and cigarettes, and research cigarettes sold under the brand name SPECTRUM. It derives a majority of its revenue from the tobacco segment.
| Founded: | 1998 | Country: | United States |
| Employees: | N/A | City: | WILLIAMSVILLE |
| Market Cap: | 2.9M | IPO Year: | N/A |
| Target Price: | N/A | AVG Volume (30 days): | 26.5K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -143.72 | EPS Growth: | N/A |
| 52 Week Low/High: | $5.18 - $1207.50 | Next Earning Date: | 03-19-2026 |
| Revenue: | $20,346,000 | Revenue Growth: | 16.98% |
| Revenue Growth (this year): | -24.28% | Revenue Growth (next year): | 79.56% |
| P/E Ratio: | N/A | Index: | N/A |
| Free Cash Flow: | -14915000.0 | FCF Growth: | N/A |
AI-Powered XXII Daily Prediction
Machine learning model trained on 25+ technical indicators
AI Recommendation
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Compare XXII vs Leading Stocks
See how XXII stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "XXII 22nd Century Group Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.